The purpose of this research study is to assess outcomes of treatment for early prostate cancer. Current treatments for early (non-metastatic) cancer may cause long-term impairments in the patients quality of life. In this study we will compare the outcomes of patients treated with two alternative brachytherapy (seed implants) techniques using a series of questionnaires.
Participants will be asked to complete a questionnaire about their health prior to treatment, at 1, 3 and 12 months after treatment and then once a year 4 more times.
Study Type
OBSERVATIONAL
Enrollment
414
An experimental arm using MRI imaging and excluding the transition zone from the target volume
Standard ultrasound-guided brachytherapy with standard target volumes
Standard ultrasound-guided brachytherapy with standard target volumes
Massachusetts General Hospital
Boston, Massachusetts, United States
RECRUITINGDana-Farber Cancer Institute/Brigham and Women's Hospital
Boston, Massachusetts, United States
RECRUITINGBeth Israel Deaconess Medical Center
Boston, Massachusetts, United States
RECRUITINGTo assess changes in generic and disease specific quality of life over time after treatment with brachytherapy for early prostate cancer
Time frame: 10 years
To compare these outcomes after two alternative brachytherapy techniques, standard ultrasound guided brachytherapy and MRI guided prostate brachytherapy (MRIGPB)
Time frame: 10 years
To identify factors associated with specific adverse outcomes.
Time frame: 10 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.